Lifeboat Foundation

Quercetin may be able to influence apoE and could be a potential therapeutic for Alzheimer’s disease.

The Apolipoprotein E connection

The most common type of dementia is Alzheimer’s disease and as the average life expectancy has risen in recent decades so has the occurrence of this and other neurodegenerative diseases. Aging is the primary risk factor for Alzheimer’s and researchers are searching for new ways to combat this devastating disease.

Continue reading “Possible approach for treating Alzheimer’s” »

The SkinGun has been waiting on that FDA approval for years.

Fight aging is a site that is highly focused on radical life extension medicine and science. They have a forecast that within five years the first meaningful life extension treatments will exist.

Senescent cell clearing overseas within five years for $5K-25K .

It’s the year 2021. A quadriplegic patient has just had one million “neural lace” microparticles injected into her brain, the world’s first human with an internet communication system using a wireless implanted brain-mind interface — and empowering her as the first superhuman cyborg. …

No, this is not a science-fiction movie plot. It’s the actual first public step — just four years from now — in Tesla CEO Elon Musk’s business plan for his latest new venture, Neuralink. It’s now explained for the first time on Tim Urban’s WaitButWhy blog.

Continue reading “Elon Musk wants to enhance us as superhuman cyborgs to deal with superintelligent AI” »

Artificial intelligence algorithms are being taught to generate art, human voices, and even fiction stories all on their own—why not give them a shot at building new ways to treat disease?

Atomwise, a San Francisco-based startup and Y Combinator alum, has built a system it calls AtomNet (pdf), which attempts to generate potential drugs for diseases like Ebola and multiple sclerosis. The company has invited academic and non-profit researchers from around the country to detail which diseases they’re trying to generate treatments for, so AtomNet can take a shot. The academic labs will receive 72 different drugs that the neural network has found to have the highest probability of interacting with the disease, based on the molecular data it’s seen.

Atomwise’s system only generates potential drugs—the compounds created by the neural network aren’t guaranteed to be safe, and need to go through the same drug trials and safety checks as anything else on the market. The company believes that the speed at which it can generate trial-ready drugs based on previous safe molecular interactions is what sets it apart.

Continue reading “Artificial intelligence could build new drugs faster than any human team” »

Tesla founder and chief executive Elon Musk said his latest company Neuralink is working to link the human brain with computers by creating micron-sized devices.

Neuralink is aiming to bring to the market a product that helps with certain severe brain injuries due to stroke and cancer lesion in about four years, Musk said in an interview with the website Wait But Why on Thursday.

“If I were to communicate a concept to you, you would essentially engage in consensual telepathy,” Musk said in the interview. Neuralink will be Musk’s third company along with Tesla and SpaceX.

Continue reading “Elon Musk’s new company wants to link human brains with computers in 4 years” »

https://www.youtube.com/watch?v=HkxgRIgo2dA

Primarily talking about CRISPR.

Daisy Robinton explores bioengineering and its potential to end ageing.

Continue reading “Daisy Robinton — The Fight Against Aging” »

In the far future, tricorders are invented and humanity spends many centuries prospering due in part to their widespread adoption. It’s too early to tell whether we’re on that timeline or a different one, but rest assured that one part of Gene Roddenberry’s quixotic vision for the future has indeed come to pass. Tricorders are coming to the mass market, courtesy of the just-awarded Tricorder XPrize.

The $2.5 million first prize went to Final Frontier Medical Devices, a team of seven including four Trekkie siblings, for their DxtER diagnostic device (below).

Continue reading “Real-life tricorders are here 230 years early, courtesy of the Tricorder XPrize” »

Starving cancer via amino acids looks like a promising approach.

Cutting out certain amino acids — the building blocks of proteins — from the diet of mice slows tumor growth and prolongs survival, according to new research published in Nature.

Researchers at the Cancer Research UK Beatson Institute and the University of Glasgow found that removing two non-essential amino acids — serine and glycine — from the diet of mice slowed the development of lymphoma and intestinal cancer.

Continue reading “Amino acids in diet could be key to starving cancer” »